BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.070
-0.030 (-2.73%)
Jul 8, 2026, 4:50 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 544.62 million as of July 8, 2026. Its market cap has decreased by -14.32% in one year.
Market Cap
544.62M
Enterprise Value
497.25M
Revenue
40.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.07
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 544.62M, an increase of 623.47%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 544.62M | 7.85% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 112.20B |
| Coloplast | 88.92B |
| Demant | 59.30B |
| ChemoMetec | 7.13B |
| Gubra | 5.24B |
| Pharma Equity Group | 100.17M |
| ViroGates | 94.68M |